Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Griffon Corporation is undergoing a major strategic transformation to become a pure-play North American building products company. By transitioning its AMES consumer lawn and garden businesses into joint ventures or divesting them, Griffon is unlocking significant value. The core Home and Building Products segment (Clopay) holds a dominant market position in residential and commercial garage doors, exhibiting robust pricing power and high EBITDA margins (25%+). Despite cyclical volume headwinds in the residential housing market, Griffon's aggressive capital allocation strategy—characterized by substantial share buybacks and consistent dividend growth—provides a strong floor for EPS expansion and shareholder returns.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets7 analysts · as of 18 Aug 2026
Low · most bearish analyst$115.00
Mean target$125.14
High · most bullish analyst$135.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario

The bear case reflects a prolonged downturn in the housing market, leading to double-digit volume declines that test Clopay's pricing power. Margin normalization occurs as steel and labor costs rise, compressing EBITDA margins toward historical levels. Delays or unfavorable terms in the final AMES Australia divestiture limit capital allocation flexibility.

Base CaseCentral scenario

The base case assumes Griffon successfully completes its portfolio simplification, closing the AMES joint ventures and exits by the end of fiscal 2026. Clopay maintains its pricing discipline, offsetting soft residential volumes with favorable price/mix. Revenue stabilizes around $1.8 billion with adjusted EBITDA margins holding above 25%. Continued share repurchases reduce the share count, driving steady EPS growth.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Dominant market position of Clopay as the largest manufacturer of residential and commercial garage doors in North America.
  • High-margin profile with adjusted EBITDA margins consistently exceeding 25% in the core building products business.
  • Aggressive capital allocation, having repurchased approximately 20% of outstanding shares since early 2023.
  • Portfolio simplification into a pure-play building products company, which historically commands higher valuation multiples.
Sign in / Sign up to read more
Key Investment Risks
  • Cyclical exposure to the North American residential housing and repair/remodel markets.
  • Sensitivity to raw material cost volatility, particularly steel, and labor cost inflation.
  • Execution risks associated with the final divestitures and joint venture transitions of the AMES segments.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. EBITDA margins in the Home and Building Products segment falling below 20% due to severe pricing pressure.
  2. A prolonged freeze in the North American housing market leading to consecutive quarters of double-digit volume declines.
  3. Failure to close the AMES Australasia joint venture or a significant write-down of the retained equity stakes.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.